Unlocking Potential: GLP-1 Agonists in Psychiatry—Promise, Pitfalls, and Perspectives

In this program, learn about the physiologic roles of the incretin hormones GLP-1 and GIP and how these inform the therapeutic benefits and potential risks of GLP-1 receptor agonists and GLP-1/GIP receptor agonists in patients with mental illness.

Share

Program Content

Activities

GLP-1 agonists in psychiatry slides
Unlocking Potential: GLP-1 Agonists in Psychiatry—Promise, Pitfalls, and Perspectives
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2024

Expires: April 21, 2025

Faculty

cover img faculity

Eric D Achtyes, MD, MS

Professor and Chair
Department of Psychiatry
Western Michigan University Homer Stryker M.D. School of Medicine
Kalamazoo, Michigan

cover img faculity

Robert O. Cotes, MD, DFAPA

Professor and Distinguished Physician
Director, Clinical & Research Program for Psychosis at Grady Health System
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is not commercially supported.

Independent Educational Activity